Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X NASDAQ 100 Covered Call ETF (QYLD) vs Select Medical Holdings Corporation (SEM) Price & Performance

Global X NASDAQ 100 Covered Call ETFTrade
Select Medical Holdings CorporationTrade

Price performance (Past 24H)

Key statistics

Global X NASDAQ 100 Covered Call ETF vs Select Medical Holdings Corporation — how do they compare? Global X NASDAQ 100 Covered Call ETF trades at $17.8, while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Select Medical Holdings Corporation pays a 1.51% dividend while Global X NASDAQ 100 Covered Call ETF pays none, and Select Medical Holdings Corporation is trading nearer its 52-week high, Global X NASDAQ 100 Covered Call ETF nearer its low. Which is the better fit depends on your goals.

QYLDSEM
Sector
Income / Options OverlayHealth
52-Week High
$18.52$16.66
52-Week Low
$16.46$11.77
Market Cap
$2.05B
Enterprise Value
$5.01B
Dividend Yield
1.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X NASDAQ 100 Covered Call ETF

QYLD trades at $17.66, down 0.84% with a bearish technical outlook. The ETF shows neutral oscillators but bearish moving averages, with RSI at oversold levels. Recent dividend payments of $0.18-$0.19 highlight its income focus, though news articles question long-term wealth erosion versus Nasdaq growth.

The outlook remains cautious due to covered-call strategy limitations during market rallies. Risks include NAV erosion and underperformance versus benchmarks. Income-focused investors may find value, but growth-oriented investors face significant upside capture constraints in bullish markets.

Select Medical Holdings Corporation

Select Medical (SEM) trades at $16.51, unchanged on the day, amid a completed acquisition by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock shows a bullish technical signal with support and resistance clustered around $17. Financially, the company reported 2025 revenue of $5.45B and net income of $146.22M, with a P/E of 15.43 and P/S of 0.36 indicating moderate valuation. Recent earnings have been mixed, with a beat in Q3 2025 but misses in Q4 2025 and Q1 2026.

The acquisition at $16.50 per share caps near-term upside, with legal investigations into the board's fiduciary duties posing a key risk. Analyst sentiment is mixed with 35.71% buy ratings but 57.15% hold, reflecting uncertainty post-buyout. Investors should note the stock's limited movement potential given the acquisition price, with fundamental performance and legal outcomes driving any residual value.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X NASDAQ 100 Covered Call ETF

QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.

Read more on QYLD

About Select Medical Holdings Corporation

Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.

Read more on SEM